12.34
Schlusskurs vom Vortag:
$11.85
Offen:
$11.89
24-Stunden-Volumen:
414.12K
Relative Volume:
1.05
Marktkapitalisierung:
$510.06M
Einnahmen:
$57.80M
Nettoeinkommen (Verlust:
$-35.29M
KGV:
-12.36
EPS:
-0.9987
Netto-Cashflow:
$-8.42M
1W Leistung:
+12.80%
1M Leistung:
+15.65%
6M Leistung:
+101.63%
1J Leistung:
+40.87%
908 Devices Inc Stock (MASS) Company Profile
Firmenname
908 Devices Inc
Sektor
Branche
Telefon
978-729-4478
Adresse
44 THIRD AVENUE, BURLINGTON
Compare MASS vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MASS
908 Devices Inc
|
12.34 | 472.86M | 57.80M | -35.29M | -8.42M | -0.9987 |
|
ABT
Abbott Laboratories
|
98.83 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
86.29 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
275.39 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.65 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.32 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | Eingeleitet | Stephens | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-01-12 | Eingeleitet | Cowen | Outperform |
| 2021-01-12 | Eingeleitet | SVB Leerink | Outperform |
| 2021-01-12 | Eingeleitet | Stifel | Buy |
| 2021-01-12 | Eingeleitet | William Blair | Outperform |
Alle ansehen
908 Devices Inc Aktie (MASS) Neueste Nachrichten
Form 4 908 Devices Inc For: 26 September By Investing.com - Investing.com Nigeria
Awm investment sells $283k in 908 Devices stock By Investing.com - Investing.com
A 10% owner sold 1,000 and 24,000 shares of 908 Devices (MASS) on consecutive days. - Stock Titan
Roth MKM Maintains 908 Devices(MASS.US) With Buy Rating, Raises Target Price to $14 - Moomoo
908 Devices Inc Lobbyists, 2025 - OpenSecrets
12 Information Technology Stocks Moving In Friday's After-Market Session - Benzinga
908 Devices Insider Sold Shares Worth $280,070, According to a Recent SEC Filing - marketscreener.com
Trading plan drives 27K-share insider sale at 908 Devices (MASS) - Stock Titan
Devices (MASS) Notches +4.64% Gain — Bulls Tighten Grip 2026-09-17Sector Leader Stocks - dars.gov.et
908 Devices (NASDAQ: MASS) officer plans sale of 27,656 shares - Stock Titan
908 Devices Inc (NASDAQ: MASS) Share Price, MASS Stock News, MASS Share Price & Updates - Kalkine
NIRLab enables agencies to detect drug trends faster, 908 Devices claims - Traders Union
CCORF Maintains 908 Devices(MASS.US) With Buy Rating, Maintains Target Price $13.5 - Moomoo
Canaccord initiates 908 Devices stock coverage with buy rating By Investing.com - Investing.com South Africa
MASS Initiates Coverage On 908 Devices -- Rating Set to Buy with $13.50 PT - GuruFocus
Canaccord initiates 908 Devices stock coverage with buy rating - investing.com
908 Devices Insider Christopher D. Brown Sells 30,000 Shares at $10.58 on September 2, 2026 (NASDAQ: MASS) - Kalkine Media
908 Devices Inc. (MASS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Eastern Progress
908 Devices: director Brown sells $317,400 of common stock - Investing.com India
908 Devices: director Brown sells $317,400 of common stock By Investing.com - Investing.com Canada
Director at 908 Devices (NASDAQ: MASS) sells 30,000 shares under 10b5-1 plan - Stock Titan
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium - Yahoo Finance
908 Devices Inc. (MASS) Presents at 17th Annual Midwest IDEAS ConferenceSlideshow - Seeking Alpha
908 Devices Raises 2026 Outlook as Handheld Detection Demand Accelerates - Yahoo Finance
908 Devices (MASS) CFO sells shares under 10b5-1 plan - Stock Titan
908 Devices CFO Joseph H. Griffith IV disposes of 11,459 common shares worth $125,476.05 - Bitget
A Look at 908 Devices Inc (MASS) After 5.7% Decline -- GF Value $7.06 vs Price $10.35 - GuruFocus
908 Devices at Midwest IDEAS Conference: focus narrows, margins improve By Investing.com - Investing.com Canada
908 Devices (MASS) officer plans $125K stock sale - Stock Titan
AWM trims 50,000-share stake in 908 Devices Inc. (MASS) stock - Stock Titan
Is 908 Devices Inc (MASS) Overvalued After 3.3% Rally? GF Value - GuruFocus
Devices (MASS) Earnings Snapshot: EPS Beats Its Estimate; Share Move: Shares Move Higher 1.59% in the Latest ReadingEarnings Call Highlights - dars.gov.et
908 Devices (MASS) Q2 2026 Earnings Call Transcript - AOL.com
908 Devices (NASDAQ:MASS) Qualifies for Minervini Trend Template and High-Growth Momentum Screen - ChartMill
908 Devices CEO Knopp sells $283,677 in common stock By Investing.com - Investing.com India
TG Therapeutics Conference: 908 Devices Bets on Handheld Drug, Chemical Detection - TradingView
908 Devices (MASS) Rises 1.80% as Shares Approach Key Resistance at $10.70Hidden Order - vinanet.vn
908 Devices CEO Knopp sells $283,677 in common stock - Investing.com
908 Devices (MASS) CEO offloads 27K shares under preset 10b5-1 plan - Stock Titan
MASS Q2 2026 Earnings: Narrowed Loss Beats Estimates by 36.6%, Shares Tick HigherAnalyst Earnings Estimate - vinanet.vn
908 Devices (NASDAQ: MASS) founder lines up new stock sale - Stock Titan
908 devices director Christopher Brown sells $169,800 in shares By Investing.com - Investing.com Canada
908 devices director Christopher Brown sells $169,800 in shares - Investing.com
Finanzdaten der 908 Devices Inc-Aktie (MASS)
Umsatz
Nettogewinn
Free Cashflow
ENV
908 Devices Inc-Aktie (MASS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 10% Owner |
Sep 23 '26 |
Sale |
11.25 |
1,000 |
11,250 |
4,755,773 |
| Kenneweg John | SVP, Sales & Product Marketing |
Sep 16 '26 |
Option Exercise |
0.96 |
21,399 |
20,543 |
79,183 |
| Kenneweg John | SVP, Sales & Product Marketing |
Sep 17 '26 |
Option Exercise |
0.96 |
5,257 |
5,047 |
63,041 |
| Kenneweg John | SVP, Sales & Product Marketing |
Sep 15 '26 |
Option Exercise |
0.96 |
1,000 |
960 |
58,784 |
| Kenneweg John | SVP, Sales & Product Marketing |
Sep 16 '26 |
Sale |
10.11 |
21,399 |
216,344 |
57,784 |
| Kenneweg John | SVP, Sales & Product Marketing |
Sep 17 '26 |
Sale |
10.22 |
5,257 |
53,727 |
57,784 |
| Kenneweg John | SVP, Sales & Product Marketing |
Sep 15 '26 |
Sale |
10.00 |
1,000 |
10,000 |
57,784 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):